MiR-149 attenuates the proliferation and migration of TGF- β1-induced airway smooth muscle cells by targeting TRPM7 and affecting downstream MAPK signal pathway.
In this study, the expression level of miR-149 in human airway smooth muscle cells (ASMCs) was decreased after TGF-β1 treatment in vitro. Additionally, the over-expression of miR-149 obviously suppressed proliferation and migration in human ASMCs. Besides, we found that overexpression of miR-149 could inhibit the expression of transient receptor potential melastatin 7 (TRPM7) both in protein and gene levels. Furthermore, we demonstrated that miR-149 could inhibit the cell proliferation and migration in human ASMCs by targeting TRPM7 through modulating mitogen-activated protein kinases (MAPKs) signaling pathway. Taken together, we strongly supported that miR-149 might be a key inhibitor of asthma by targeting TRMP7. Therefore, our finding suggests a promising biomarker for the development of further targeted therapies for asthma.
PMID: 33284571 [PubMed - as supplied by publisher]
Source: Acta Biochim Pol - Category: Biochemistry Authors: Zhu Z, Zhang L, Jiang T, Qian Y, Sun Y, Zhang Q Tags: Acta Biochim Pol Source Type: research
More News: Asthma | Biochemistry | Cancer | Cancer & Oncology | Genetics | Respiratory Medicine | Study